Case studies of SARS-CoV-2 treated with favipiravir among patients in critical or severe condition

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak is rising globally. However, clinically effective antiviral treatments are not established. Favipiravir may prevent pneumonia and acute respiratory distress syndrome aggravation. We describe SARS-CoV-2-positive patients, two of whom were in a critical condition and one of whom was in a severe condition, who were administered favipiravir for their deteriorating conditions and cured.

Keywords: COVID-19; SARS-CoV-2; acute respiratory distress syndrome; favipiravir; viral pneumonia.